Skip to main content
. 2020 Dec 11;35(1):75–87. doi: 10.1007/s40259-020-00456-5

Fig. 4.

Fig. 4

Biosimilar etanercept market shares for the 14 health boards in Scotland, calculated as volume (defined daily doses) of the biosimilars over volume of the biosimilars plus reference product, from 2016 to 2018